Cruz ARE, Arbolaez GMC, González CY, Pérez DL

Language: Spanish
References: 8
Page: 65-69
PDF size: 368.39 Kb.

ABSTRACT

It presents a female patient of the sixth decade of life, with a history of polycystic kidney disease and high blood pressure, which arrives at the chronic kidney disease stage V, so she was treated with continuous ambulatory peritoneal dialysis for two years. She received a kidney transplant from a cadaveric donor who required ablation a week after her implantation due to an intrarenal thrombosis. She was incorporated into therapy with periodic hemodialysis thereafter presented different episodes of bacterial infections in different locations that were resolved with antimicrobials according to the in vitro susceptibility of the isolated microorganisms. The presence of persistent fever in the absence of isolated pathogens in the usual means, including bacteria and viruses, involved the pertinence of cultivating the peritoneal fluid, which revealed the presence of Aspergillus spp. and, therefore, the diagnosis of fungal peritonitis.

REFERENCES

1. Cruz RE, Camacho SI, Hernández OA, Hernández ME, Batista R. Experiencia en el tratamiento de la infección bacteriana en receptores de trasplante renal. Rev Cubana Med [Internet]. 2016 [citado 7 Abr 2017];55(1): [aprox. 13 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232016000100002

2. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010 Jul-Ago;30(4):393-423. doi: 10.3747/pdi.2010.00049.

3. Deng CY, Ming CW, Wei HL, An BW, Junne MS, Meng FC, et al. Peritoneal Dialysis-Related fungal peritonitis: Twenty-year experience of a Medical Center in Southern Taiwan. Acta Nephrologica. 2012;26(3):149-54. DOI: 10.6221/AN.2012004.

4. Kumar KV, Mallikarjuna HM, Gokulnath B, Jayanthi S. Fungal peritonitis in continuous ambulatory peritoneal dialysis: The impact of antifungal prophylaxis on patient and technique outcomes. Indian J Nephrol. 2014 Sep;24(5):297-301. doi: 10.4103/0971-4065.133005.

5. Narain U, Gupta A. Role of predictors and rapid diagnosis of fungal peritonitis in CAPD patients. Int J Adv Med [Internet]. 2016 [citado 7 Abr 2017];3(1):130-5. Disponible en: http://www.ijmedicine.com/index.php/ijam/article/view/245

6. Cuenca M. Diagnóstico de laboratorio de la enfermedad fúngica invasora. Enferm Infecc Microbiol Clín [Internet]. 2012 [citado 7 Abr 2017];30(5):257-64. Disponible en: http://www.elsevier.es/es-revista-enfermedades-infecciosas-microbiologia-clinica-28-articulo-diagnostico-laboratorio-enfermedad-fungica-invasora-S0213005X1200064X

7. Tao L, Yu JH. AbaA and WetA govern distinct stages of Aspergillus fumigatus development. Microbiology. 2011 Feb;157(Pt 2):313-26. doi: 10.1099/mic.0.044271-0. Epub 2010 Oct 21.

8. Azanza JR, Sádaba B, Gómez A. Farmacología de los antifúngicos en el tratamiento de la aspergilosis. Rev Iberoam Micol [Internet]. 2014 [citado 7 Abr 2017];31(4): 255-61. Disponible en: http://www.elsevier.es/es-revista-revista-iberoamericana-micologia-290-articulo-farmacologia-los-antifungicos-el-tratamiento-S1130140614000448